Valuation Metrics Indicate Improved Price Attractiveness
At the heart of Vivid Global’s valuation reassessment lies its price-to-earnings (P/E) ratio, which currently stands at 29.40. This figure marks a significant moderation compared to its historical premium levels and places the company comfortably within a fair valuation band relative to its peers. The price-to-book value (P/BV) ratio of 1.14 further supports this view, suggesting that the stock is trading close to its net asset value, a stark contrast to the expensive multiples seen in comparable firms.
Enterprise value to EBITDA (EV/EBITDA) at 9.75 and EV to EBIT at 15.40 also underscore a more balanced valuation stance. These multiples are notably lower than those of several industry peers, such as Titan Biotech and Sanstar, which command EV/EBITDA ratios exceeding 65 and 72 respectively, signalling that Vivid Global is now priced more attractively on an operational earnings basis.
Peer Comparison Highlights Relative Value
When benchmarked against other commodity chemical companies, Vivid Global’s valuation metrics reveal a compelling case for investors seeking value within the micro-cap segment. For instance, Titan Biotech is classified as very expensive with a P/E ratio of 80.39 and an EV/EBITDA multiple of 65.49, while Sanstar and Stallion India also trade at elevated multiples. Conversely, companies like TGV Sraac and Gulshan Polyols are deemed very attractive, with P/E ratios of 8.09 and 23.59 respectively, but these firms differ in scale and operational profiles.
Vivid Global’s PEG ratio of 0.46 is particularly noteworthy, indicating that the stock’s price growth is modest relative to its earnings growth potential. This low PEG ratio contrasts sharply with Titan Biotech’s 3.84, suggesting that Vivid Global may offer a more favourable risk-reward profile for growth-oriented investors.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Financial Performance and Returns Contextualise Valuation
Despite the improved valuation, Vivid Global’s return on capital employed (ROCE) and return on equity (ROE) remain modest at 3.22% and 3.86% respectively. These figures highlight ongoing challenges in operational efficiency and profitability, which investors should weigh against the stock’s valuation appeal.
From a price performance perspective, the stock has delivered a robust 25.83% return over the past year, significantly outperforming the Sensex’s decline of 1.67% over the same period. Year-to-date, Vivid Global has gained 13.91%, while the benchmark index has fallen by 13.04%. However, over longer horizons such as three and five years, the stock’s returns have lagged the Sensex, with a negative 8.87% versus a 23.86% gain over three years, and 9.51% against 50.62% over five years. This mixed performance underscores the importance of valuation adjustments in the current market environment.
Price Movements and Market Capitalisation
Trading at ₹19.00 per share, down 1.40% on the day from a previous close of ₹19.27, Vivid Global remains near its 52-week high of ₹21.84, while comfortably above its 52-week low of ₹12.18. The stock’s micro-cap status reflects its relatively small market capitalisation, which can contribute to higher volatility but also potential for price discovery as valuation perceptions evolve.
Sector Dynamics and Valuation Implications
The commodity chemicals sector has experienced varied valuation trends, with some companies commanding premium multiples due to superior growth prospects or niche market positions. Vivid Global’s transition to a fair valuation grade suggests that investors are recognising a more balanced risk profile, possibly driven by stabilising earnings and improved market sentiment.
However, the company’s modest profitability metrics and micro-cap classification imply that investors should maintain a cautious stance, balancing the stock’s relative valuation attractiveness against operational risks and sector cyclicality.
Vivid Global Industries Ltd or something better? Our SwitchER feature analyzes this micro-cap Commodity Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Mojo Score Upgrade Reflects Changing Market Perception
MarketsMOJO’s recent upgrade of Vivid Global’s Mojo Grade from Sell to Hold, effective 30 March 2026, aligns with the valuation shift and improved price metrics. The current Mojo Score of 54.0 places the stock in a neutral zone, signalling neither strong buy nor sell sentiment. This balanced rating reflects the company’s fair valuation, tempered by its modest returns and micro-cap risks.
Investors should note that while the valuation parameters have improved, the company’s dividend yield remains unavailable, and profitability ratios such as ROCE and ROE are subdued. These factors suggest that while the stock may offer value relative to peers, it is not without operational challenges that could impact medium-term performance.
Conclusion: Valuation Reset Offers Opportunity with Caution
Vivid Global Industries Ltd’s recent valuation recalibration from expensive to fair marks a significant development for investors monitoring the commodity chemicals sector. The moderation in P/E and P/BV ratios, alongside reasonable EV/EBITDA multiples, positions the stock as a more attractive option within its peer group, especially when contrasted with highly valued competitors.
However, the company’s modest profitability metrics and micro-cap status necessitate a cautious approach. The upgrade to a Hold rating by MarketsMOJO reflects this balanced outlook, suggesting that while the stock is no longer overvalued, it may require further operational improvements to justify a more bullish stance.
For investors seeking exposure to commodity chemicals with a focus on valuation discipline, Vivid Global presents a compelling case for consideration, provided they remain mindful of the inherent risks and sector cyclicality.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
